Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
Korean Circ J. 2016 Jul;46(4):472-480. English. Original Article.
Lee BK , Koo BK , Nam CW , Doh JH , Chung WY , Cho BR , Fearon WF .
Division of Cardiology, Kangwon National University School of Medicine, Chuncheon, Korea.
Division of Cardiology, Seoul National University Hospital, Seoul, Korea.
Division of Cardiology, Keimyung University Dongsan Medical Center, Daegu, Korea.
Division of Cardiology, Inje University Ilsan-Paik Hospital, Goyang, Korea.
Division of Cardiology, Seoul National University Boramae Medical Center, Seoul, Korea.
Department of Cardiovascular Medicine, Stanford University Medical Center, Stanford, CA, USA.

BACKGROUND AND OBJECTIVES: There is controversy surrounding whether or not high dose statin administration before percutaneous coronary intervention (PCI) decreases peri-procedural microvascular injury. We performed a prospective randomized study to investigate the mechanisms and effects of pre-treatment high dose atorvastatin on myocardial damage in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) undergoing PCI. SUBJECTS AND METHODS: Seventy seven patients with NSTE-ACS were randomly assigned to either the high dose group (atorvastatin 80 mg loading 12 to 24 h before PCI with a further 40 mg loading 2 h before PCI, n=39) or low dose group (atorvastatin 10 mg administration 12 to 24 h before PCI, n=38). Index of microcirculatory resistance (IMR) was measured after stent implantation. Creatine kinase-myocardial band (CK-MB) and high sensitivity C-reactive protein (CRP) levels were measured before and after PCI. RESULTS: The baseline characteristics were not different between the two patient groups. Compared to the low dose group, the high dose group had lower post PCI IMR (14.1±5.0 vs. 19.2±9.3 U, p=0.003). Post PCI CK-MB was also lower in the high dose group (median: 1.40 ng/mL (interquartile range [IQR: 0.75 to 3.45] vs. 4.00 [IQR: 1.70 to 7.37], p=0.002) as was the post-PCI CRP level (0.09 mg/dL [IQR: 0.04 to 0.16] vs. 0.22 [IQR: 0.08 to 0.60], p=0.001). CONCLUSION: Pre-treatment with high dose atorvastatin reduces peri-PCI microvascular dysfunction verified by post-PCI IMR and exerts an immediate anti-inflammatory effect in patients with NSTE-ACS.

Copyright © 2019. Korean Association of Medical Journal Editors.